Longpara 665 mg (Tablet (Extended Release))
Unit Price: ৳ 2.00 (20 x 10: ৳ 400.00)
Strip Price: ৳ 20.00
Medicine Details
Category | Details |
---|---|
Generic | Paracetamol |
Company | Ibn sina pharmaceuticals ltd |
Also available as |
Indications
- Fever
- Common cold
- Influenza
- Headache
- Toothache
- Earache
- Bodyache
- Myalgia
- Neuralgia
- Dysmenorrhoea
- Sprains
- Colic pain
- Back pain
- Post-operative pain
- Postpartum pain
- Inflammatory pain
- Post vaccination pain in children
- Rheumatic pain
- Osteoarthritic pain
- Stiffness of joints
Pharmacology
- Analgesic properties
- Antipyretic properties
- Weak anti-inflammatory activity
- Acts in the central nervous system (CNS)
- Increases the pain threshold
- Inhibits cyclooxygenase (COX) enzymes
- Prostaglandin (PG) synthesis inhibition
- Para aminophenol derivative
Dosage & Administration
- Tablet:
- Adult dosage: 1-2 tablets every 4 to 6 hours up to a maximum of 4 gm (8 tablets) daily
- Children (6-12 years) dosage: ½ to 1 tablet 3 to 4 times daily
- Extended Release Tablet:
- Adults & Children over 12 years dosage: Two tablets every 6 to 8 hours (maximum of 6 tablets in any 24 hours)
- Syrup/Suspension:
- Dosage for Children under 3 months, 3 months to below 1 year, 1-5 years, 6-12 years, and Adults
- Suppository:
- Dosage for Children 3-12 months, 1-5 years, 6-12 years, Adults & children over 12 years
- Paediatric Drop:
- Dosage for Children up to 3 months, 4 to 11 months, 7 to 2 years
- Paracetamol tablet with actizorb technology:
- Adults and children (aged 12 years and over) dosage
- Children (7 to 11 years) dosage
Interaction
- Diminished ability to metabolize large doses with barbiturates, tricyclic antidepressants, and alcohol
- Increased hepatotoxicity in case of Longpara overdosage with alcohol
- Chronic ingestion of anticonvulsants or oral steroid contraceptives may prevent attainment of therapeutic Longpara levels
Contraindications
- Known hypersensitivity to Paracetamol
Side Effects
- Mild side effects
- Haematological reactions including thrombocytopenia, leucopenia, pancytopenia, neutropenia, and agranulocytosis
- Pancreatitis
- Skin rashes
- Other allergic reactions
Pregnancy & Lactation
- Epidemiological studies show no ill effects in human pregnancy
- Excretion in breast milk in not a clinically significant amount
Precautions & Warnings
- Care in administration to patients with severe renal or severe hepatic impairment
- Hazard of overdose is greater in non-cirrhotic alcoholic liver disease patients
- Advised not to exceed the stated dose
- Not to be taken concurrently with other Longpara-containing products
- Use only when clearly necessary
Overdose Effects
- Possible liver damage in adults who have taken 10 g or more of Longpara
- Liver damage risk in ingestion of 5 g or more with certain risk factors
- Symptoms of Longpara overdose
- Immediate treatment essential
- Plasma Longpara concentration measurement
- Treatment with activated charcoal and N-acetylcysteine
Therapeutic Class
- Non opioid analgesics
Storage Conditions
- Keep in a dry place away from light and heat
- Keep out of the reach of children
Chemical Structure
- Molecular Formula: C8H9NO2
- Chemical Structure Image: https://medex.com.bd/storage/res/g-res-860-paracetamol-chemical-structure-JLKHDuG7hxR2MserFZ27.svg
Common Questions about Longpara 665 mg Tablet
- Medication action by obstructing release of pain and fever chemical messengers
- Uses for treatment and prevention of conditions and symptoms of diseases like Post immunization pyrexia, menstrual cramps, and fever
- Possible side effects including allergic reaction, gastric ulcers, fatigue, anemia, nausea, and vomiting
- Instructions for storage and disposal
- Advice for taking with food or milk to prevent upset stomach
Related Brands
- M-Pol 500 mg (Tablet) - modern-pharmaceuticals-ltd
- M-Pol 120 mg/5 ml (Oral Suspension) - modern-pharmaceuticals-ltd
- Napa 500 mg (Tablet) - beximco-pharmaceuticals-ltd
- Napa Extend 665 mg (Tablet (Extended Release)) - beximco-pharmaceuticals-ltd
- Napa 120 mg/5 ml (Oral Suspension) - beximco-pharmaceuticals-ltd